← Leaderboards
Judson M Englert
University Of Pittsburgh At Pittsburgh
$125,598
Attributed
$125,598
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $43.8K · FY2008–10$50K$37.5K$25K$12.5K$0
'08
'09
'10
Funding mix
By agency
NIH$125,598 · 1
By mechanism
F30$125,598 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Joseph C. Glorioso$19,383,290
- Carol A Feghali-Bostwick$17,984,586
- Nirmala Sundarraj$4,169,469
- Tim D Oury$3,476,856
- Corrine R Kliment$3,706,560
Others in their field
Top investigators on “Epidemiologic Studies”
- David Heimbrook · Leidos Biomedical Research, Inc.$381,100,069
- George R Seage · Abt Associates, Inc.$298,440,737
- Jeffrey P Krischer · University Of South Florida$264,076,260
- James Dennis Neaton · Northwestern University$203,539,316
- Gregory H Reaman · National Childhood Cancer Foundation$199,902,467
- Carol Nesel · Westat$188,148,170
Research focus
Epidemiologic StudiesEpithelialDiabetic MouseEnzyme-Linked Immunosorbent AssayEnvironmental ExposureAffinityAsbestosisA549DustBinding (Molecular Function)AsbestosBreathingCell LineCellsCollagenCollagen Type IvAtherosclerosisAlveolarBasement MembraneAnimalsDepositionDiabetes MellitusDiabeticEpithelial Cells
Grant awards (3)
A Role for Advanced Glycation End-Products in Diabetic Lung Injury$43,818
F30 · FY2010 · ES · contact PI
A Role for Advanced Glycation End-Products in Diabetic Lung Injury$40,992
F30 · FY2009 · ES · contact PI
A Role for Advanced Glycation End-Products in Diabetic Lung Injury$40,788
F30 · FY2008 · ES · contact PI